Sky News - back to home 3 Feb 8° 6° Watch Live Home UK Politics World US Money Science, Climate & Tech Ents & Arts Programmes New, Puzzles Videos More CancerCancer Top Stories New bowel cancer detection method more than 90% accurate, research finds 30 Jan30th January...
Cancer Research UK said that concerning delays to begin treatment in the UK are partly a result of the UK Government's lack of long-term planning on cancer in recent decades. Countries with more robust cancer strategies backed by sufficient funding have seen larger improvements in survival than ...
"There was no difference in prostate cancer mortality at 15 years between the groups," Loeb said. And prostate cancer survival for all three groups was high — 97% regardless of treatment approach. "That's also very good news." The results were published Saturday in the New England Journal ...
The National Institute for Health and Care Excellence (NICE) decided in March this year that patients should be denied access to Enhertu because it said the drug did not provide value for money.
UK News|Dec 31, 2024 Mother who helps children with cancer speaks of heartache as she is made MBE UK News|Dec 31, 2024 King honours medical staff for personal service during his cancer treatment UK News|Dec 31, 2024 Inspector Morse star Kevin Whately made OBE in New Year Honours ...
Reference to a study published in the April 2, 2005 issue of the "British Medical Journal"; Status of prostate cancer in Great Britain in terms of treatment; Comparison between the cancer research funding in the U.S. and in the European Union....
GIST Cancer UK and Sarcoma UK announce joint research funding All News ArticlesGIST NewsPatient Meetings NewsTreatment News Newsletter – Spring 2024 1 2 3 4 GIST Cancer Support & Information for when you need it... Personal Support » ...
Results from a trial involving 1643 men in the UK aged 50 to 69 years with localized prostate cancer showed that, after 15 years of follow-up, deaths from
(AP) -- An independent British medical watchdog says the first treatment proven to help people with the deadliest form of skin cancer is too expensive to be used by the U.K.'s health care system, a recommendation critics called a potential death sentence
In a release, Lynda Thomas, chief executive of Macmillan Cancer Support, commented: "While it is great news that more people are surviving cancer or living longer with it, progress is a double-edged sword." "As numbers surge, the NHS will soon be unable to cope with the huge increase in...